Enzo Biochem (NYSE:ENZ) Earns Hold Rating from Analysts at StockNews.com

StockNews.com initiated coverage on shares of Enzo Biochem (NYSE:ENZ) in a research report report published on Thursday morning. The firm issued a hold rating on the medical research company’s stock.

Enzo Biochem Price Performance

Shares of ENZ opened at $0.49 on Thursday. Enzo Biochem has a twelve month low of $0.41 and a twelve month high of $1.38. The firm has a 50 day moving average of $0.62 and a 200 day moving average of $0.93.

Enzo Biochem (NYSE:ENZ) last posted its earnings results on Monday, December 16th. The medical research company reported ($0.05) EPS for the quarter. Enzo Biochem had a negative return on equity of 7.96% and a negative net margin of 75.34%.

Institutional Trading of Enzo Biochem

A number of institutional investors have recently made changes to their positions in ENZ. Virtu Financial LLC purchased a new position in shares of Enzo Biochem during the fourth quarter valued at approximately $35,000. BBR Partners LLC purchased a new stake in Enzo Biochem during the 3rd quarter valued at $112,000. Lepercq Multi Asset Fund bought a new position in shares of Enzo Biochem during the 4th quarter valued at $88,000. Wittenberg Investment Management Inc. boosted its stake in shares of Enzo Biochem by 60.1% in the 4th quarter. Wittenberg Investment Management Inc. now owns 187,537 shares of the medical research company’s stock worth $134,000 after buying an additional 70,400 shares during the last quarter. Finally, Geode Capital Management LLC grew its holdings in shares of Enzo Biochem by 3.3% in the third quarter. Geode Capital Management LLC now owns 368,646 shares of the medical research company’s stock worth $413,000 after acquiring an additional 11,742 shares during the period. Hedge funds and other institutional investors own 36.90% of the company’s stock.

About Enzo Biochem

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.